Levocetirizin Saft Ucb Pharma (Levocetirizine Dihydrochloride)

Levocetirizine selectively blocks peripheral H1 histamine receptors. By preventing histamine from binding to these receptors on mast cells and other cells, it stops the cascade that leads to vasodilation, increased vascular permeability and nerve stimulation, thereby reducing the early allergic response.

The exact dose is determined by the prescribing clinician based on the patient’s age, weight, renal function and severity of symptoms. Typical adult regimens are often one once‑daily dose, but the prescriber will specify the appropriate volume of the oral solution for each individual.

Safety data in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

Enquiries are submitted via the product page on gnhindia.com. Provide the required quantity and institutional credentials. GNH India’s team will verify trade or institutional eligibility, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levocetirizin is the active enantiomer of cetirizine, offering similar efficacy with a slightly lower incidence of sedation. Compared with first‑generation antihistamines, it provides more selective H1 blockade and fewer anticholinergic side effects, making it a preferred option for many patients requiring daily allergy control.

The oral solution should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and extreme temperature fluctuations to maintain potency throughout its shelf life.

The medication is taken orally as a measured dose of the syrup, usually once daily. It can be administered with or without food. A calibrated dosing spoon or oral syringe should be used to ensure accurate measurement.

Serious adverse events, although rare, include anaphylactic reactions, severe skin disorders such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, and cardiac arrhythmias like QT‑interval prolongation. Immediate medical attention is required if any of these symptoms appear.

Patients with known hypersensitivity to levocetirizine, its salts, or any component of the formulation should avoid the product. Caution is also advised for individuals with severe renal impairment, as dose adjustment may be necessary, and for those taking medications that could cause dangerous interactions.